Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21)

The purpose of this grant is to support studies to better comprehend the mechanisms contributing to the CNS co-morbidities in people living with HIV on Anti-Retroviral therapy by deciphering the Immune-Central Nervous System (CNS) interactions. Exploratory and high-risk research projects are appropriate for this FOA

Basic and preclinical research in domestic and international settings are of interest.

Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Funding: $275,000

Duration: 2 years

Research Authority due date: 1.11.21

LOI (encouraged) due date: 7.11.21

Full proposal due date: 7.12.21